Myoblast transplantation ( DrugBank: - )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 113 | Muscular dystrophy | 1 |
113. Muscular dystrophy
Clinical trials : 622 / Drugs : 485 - (DrugBank : 99) / Drug target genes : 59 - Drug target pathways : 168
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02196467 (ClinicalTrials.gov) | May 2014 | 9/5/2014 | Transplantation of Myoblasts to Duchenne Muscular Dystrophy (DMD) Patients | Transplantation of Myoblasts to Duchenne Muscular Dystrophy (DMD) Patients | Duchenne Muscular Dystrophy | Biological: Myoblast transplantation;Procedure: Saline injection | CHU de Quebec-Universite Laval | NULL | Recruiting | 16 Years | N/A | Male | 10 | Phase 1/Phase 2 | Canada |